多发性脑转移瘤伽玛刀放射外科毒性的建模
本研究纳入245例患者共1217个脑转移瘤(单次或分次伽玛刀治疗)进行回顾性分析,发现肿瘤表面积是12 Gy正常脑体积(V12)的最佳单变量线性预测因子(adjR2=0.770),并建立仅用计划前变量(归一化处方剂量Rxn与最长轴径LAD)的幂律模型V12∼Rxn1.5*LAD2,该模型在独立验证集63例302个转移瘤中预测能力得到验证。
要点
- 肿瘤表面积是V12最准确的单变量预测因子(adjR2=0.770)。
- 幂律模型V12∼Rxn1.5*LAD2解释1217个病灶V12变异的90%(adjR2=0.906)。
- 该计划前模型可估算放射性坏死风险、确定处方剂量并支持安全剂量递增。
核心结论
- 对于转移性病灶,表面积是V12最准确的单变量预测因子,所开发的计划前模型有助于更好地估算放射性坏死风险、在给定目标V12时确定处方剂量,并提供无需任何计划软件的安全剂量递增策略。
研究设计与样本
- 回顾性分析245例患者共1217个脑转移瘤,接受单次或分次伽玛刀治疗,采用单变量与多变量线性回归模型及幂律模型确定预测V12的最佳参数。
- 幂律模型V12∼Rxn1.5*LAD2(Rxn为归一化处方剂量,LAD为肿瘤最长轴径)在第二组63例患者共302个脑转移瘤中独立验证。
主要发现
- 表面积是V12的最佳单变量线性预测因子(adjR2=0.770),其次为最长轴径(adjR2=0.755)和体积(adjR2=0.745)。
- 预测V12与实测V12的平均差值ΔV12为每个病灶(0.28±0.55)cm3,每例患者(1.0±1.2)cm3。
- 幂律模型预测能力在第二组63例患者数据集(adjR2=0.867)及302个脑转移瘤(adjR2=0.825)中得到验证。
关键数值与推荐
- 单次放射外科方案依据假定放射性坏死风险设定剂量标准,该风险可由12 Gy正常脑体积(V12)预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiation oncology protocols for single fraction radiosurgery recommend setting dosing criteria based on assumed risk of radionecrosis, which can be predicted by the 12 Gy normal brain volume (V12). In this study, we show that tumor surface area (SA) and a simple power-law model using only preplan variables can estimate and minimize radiosurgical toxicity. MATERIALS AND METHODS: A 245-patient cohort with 1217 brain metastases treated with single or distributed Gamma Knife sessions was reviewed retrospectively. Univariate and multivariable linear regression models and power-law models determined which modeling parameters best predicted V12. The V12 power-law model, represented by a product of normalized Rx dose Rxn, and tumor longest axial dimension LAD (V12 ∼ Rxn1.5*LAD2), was independently validated using a secondary 63-patient cohort with 302 brain metastases. RESULTS: Surface area was the best univariate linear predictor of V12 (adjR2 = 0.770), followed by longest axial dimension (adjR2 = 0.755) and volume (adjR2 = 0.745). The power-law model accounted for 90% variance in V12 for 1217 metastatic lesions (adjR2 = 0.906) and 245 patients (adjR2 = 0.896). The average difference ΔV12 between predicted and measured V12s was (0.28 ± 0.55) cm3 per lesion and (1.0 ± 1.2) cm3 per patient. The power-law predictive capability was validated using a secondary 63-patient dataset (adjR2 = 0.867) with 302 brain metastases (adjR2 = 0.825). CONCLUSION: Surface area was the most accurate univariate predictor of V12 for metastatic lesions. We developed a preplan model for brain metastases that can help better estimate radionecrosis risk, determine prescription doses given a target V12, and provide safe dose escalation strategies without the use of any planning software.
引用
- Hsu EJ, Yan Y, Timmerman RD, et al. Modeling gamma knife radiosurgical toxicity for multiple brain metastases. Radiother Oncol. 2023. PMID: 37640162. doi:10.1016/j.radonc.2023.109874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。